tripelennamine has been researched along with Respiratory Insufficiency in 1 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Respiratory Insufficiency: Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| RINKER, JR | 1 |
| SULLIVAN, JH | 1 |
1 other study available for tripelennamine and Respiratory Insufficiency
| Article | Year |
|---|---|
DRUG REACTIONS FOLLOWING URETHRAL INSTILLATION OF TRIPELENNAMINE (PYRIBENZAMINE).
Topics: Anesthesia; Anesthesia, Local; Anesthesiology; Cystoscopy; Geriatrics; Humans; Hypertension; Male; R | 1964 |